Fortress Biotech
FBIOPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$499.098 M
$14.97 -0.63%
Close of 6 Nov 2026
As of 6 Nov 2026, Fortress Biotech (FBIOP) has a market capitalization of $499.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$63.3M
#2639 by revenue
Earnings
$37.0M
#1670 by earnings
Shares outstanding
33,311,012
Latest filing cover page
P/E ratio
13.5
Cap ÷ net income
Other share classes
Fortress Biotech lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Fortress Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.